Highlight
- Early insulin therapy within 6 hours of moderate hyperglycemia onset reduces 30-day mortality by 2.3% compared to delayed or no treatment in ICU patients.
- Initiating insulin within 1 to 2 hours following hyperglycemia yields markedly greater absolute mortality reductions, up to 7.7 percentage points.
- These findings, derived from a real-world target trial emulation of 5,755 ICU patients, underscore the importance of timely glucose control interventions in critical care.
- Mortality benefits varied across subgroups, suggesting potential patient-specific factors influence insulin therapy effectiveness.
Specialty calculators
For clinical reference; use professional judgment.

